Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (751-760 of 777) with videos related to

Pageof 78
Sort By:
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Journal of Hepatology|August 7, 2025
Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathyTeresa Brevini, Lisa Swift, Helen Reynolds, et al.
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)Malin Fromme, Karim Hamesch, Carolin V Schneider, et al.
Journal of Hepatology|October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY scoreBernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
Cell Metabolism|December 3, 2014
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolismEgon Demetz, Andrea Schroll, Kristina Auer, et al.
JHEP Reports : Innovation in Hepatology|December 29, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinomaBernhard Scheiner, Daniel Roessler, Samuel Phen, et al.
Gut|February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Vitor Pereira, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
Pageof 78

Showing results (751-760 of 777) with videos related to

Sort By:
Pageof 78
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Journal of Hepatology|August 7, 2025
Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathyTeresa Brevini, Lisa Swift, Helen Reynolds, et al.
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)Malin Fromme, Karim Hamesch, Carolin V Schneider, et al.
Journal of Hepatology|October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY scoreBernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
Cell Metabolism|December 3, 2014
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolismEgon Demetz, Andrea Schroll, Kristina Auer, et al.
JHEP Reports : Innovation in Hepatology|December 29, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinomaBernhard Scheiner, Daniel Roessler, Samuel Phen, et al.
Gut|February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Vitor Pereira, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
Pageof 78